Literature DB >> 15535956

The comparative pathogenicity of strains of eight serovars and untypable strains of Mannheimia haemolytica in experimental pneumonia of sheep.

Moses O Odugbo1, Lillian E Odama, Jarlath U Umoh, Lami H Lombin.   

Abstract

The experimental induction of pneumonic pasteurellosis in groups of conventionally reared lambs by 8 serovars (A1, A2, A6, A7, A8, A9, T10, and A11) and untypable (UT) strains of Mannheimia haemolytica (Mh) were examined and compared. The groups of lambs were inoculated intratracheally with 1.4 x 10(8) +/- 0.6 x 10(8) (mean +/- SD) colony-forming units of the Mh serovars or UT isolates in the 6-hour log phase of growth. The variables measured as indicators of disease severity were clinical score, percentage lung consolidation and microbiological re-isolation. The clinical parameters for each group were computed daily for 6 days post infection and the lambs which died were necropsied while the remaining lambs were killed on day 7 pi and the extent of lung consolidation was measured. Clinically, the mean scores for the M. haemolytica serovars were A1 (6.1), A2 (18.8), A6 (0.5), A7 (17.4) and A9 (8.5). The mean percent lung lesion scores for M. haemolytica serovars were A1 (12.5), A2 (66.3), A6 (5.0), A7 (51.3), A9 (33.8) and A11 (2.5). The percent mean pneumonic lung lesions recorded for groups inoculated with A2, A7 and A9 were significantly (P < 0.05) higher than the extent of lung lesions in the other groups. A statistically significant correlation was observed between clinical scores and the severity of the lung lesions (r = 0.96, P < 0.01). High titres of M. haemolytica were recovered from lung lesions, with 10 to 100 times the number of organisms inoculated being present in the lung lesions of lambs inoculated with serovars A2 and A7. These data indicate that although M. haemolytica serovars A1, A2, A6, A7, A9 and A11 are important primary lung pathogens of lambs, serovars A2, A7, and A9 are to be regarded as highly virulent strains that have a greater predilection than the other serovars for causing pneumonia in lambs.

Entities:  

Mesh:

Year:  2004        PMID: 15535956     DOI: 10.1051/vetres:2004044

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  5 in total

1.  A Preliminary Investigation on a Commercial Ovine Pasteurellosis Vaccine Using Clinical and Pathological Endpoints.

Authors:  Mersha Asfaw; Menur Senbit; Mohammed Yesuf; Melkie Dagnaw; Girma Birhan; Anmaw Shite Abat; Saddam Mohammed Ibrahim
Journal:  Infect Drug Resist       Date:  2022-06-08       Impact factor: 4.177

2.  Serotyping and Seroprevalence of Mannheimia haemolytica, Pasteurella multocida, and Bibersteinia trehalosi and Assessment of Determinants of Ovine Pasteurellosis in West Amhara Sub-region, Ethiopia.

Authors:  Kalkidan Getnet; Bezawit Abera; Haymanot Getie; Wassie Molla; Sefinew Alemu Mekonnen; Bemrew Admassu Megistu; Anmaw Shite Abat; Haileyesus Dejene; Mastewal Birhan; Saddam Mohammed Ibrahim
Journal:  Front Vet Sci       Date:  2022-05-19

3.  Intact signal peptide of CD18, the beta-subunit of beta2-integrins, renders ruminants susceptible to Mannheimia haemolytica leukotoxin.

Authors:  Sudarvili Shanthalingam; Subramaniam Srikumaran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

4.  Isolation and Molecular Detection of Pasteurellosis from Pneumonic Sheep in Selected Areas of Amhara Region, Ethiopia: An Implication for Designing Effective Ovine Pasteurellosis Vaccine.

Authors:  Aragaw Ebabu Akane; Gashaw Alemu; Kidest Tesfaye; Destaw Asfaw Ali; Takele Abayneh; Ambaye Kenubih; Mebrat Ejo; Anmaw Shite Abat; Bemrew Admassu; Saddam Mohammed Ibrahim
Journal:  Vet Med (Auckl)       Date:  2022-04-24

5.  Small ruminant pasteurellosis in Tigray region, Ethiopia: marked serotype diversity may affect vaccine efficacy.

Authors:  K Berhe; G Weldeselassie; J Bettridge; R M Christley; R D Abdi
Journal:  Epidemiol Infect       Date:  2017-01-23       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.